HEART评分中三种肌钙蛋白在急诊预测30天主要不良心脏事件的表现
本研究为单中心前瞻性队列研究,纳入急诊胸痛患者,入院时单次采血检测hsTnT、hsTnI和cTnI,按改良HEART评分分为低危和非低危组,主要终点为30天MACE。三种检测方法对应的改良HEART评分对30天MACE的敏感性为84.9-87.0%,NPV为95.6-96.0%(95%CI),AUC为0.70-0.71,特异性为53.7-56.7%(95%CI),均无很高AUC和特异性。使用hsTnT 3.9ng/L、hsTnI 0.9ng/L或cTnI 0.0ng/L单次采血截断值时,改良HEART评分对30天MACE的敏感性达100%。作者认为三种肌钙蛋白在风险分层和安全离院方面效果相同,理论截断值(达到时)可能有助于急诊安全离院低危未分化胸痛患者。
要点
- 三种肌钙蛋白(hsTnT、hsTnI、cTnI)对应的改良HEART评分对30天MACE敏感性84.9-87.0%、NPV 95.6-96.0%(95%CI),但AUC仅0.70-0.71、特异性53.7-56.7%(95%CI)。
- 单次采血hsTnT 3.9ng/L、hsTnI 0.9ng/L或cTnI 0.0ng/L作为截断值时,改良HEART评分对30天MACE的敏感性达100%。
- 作者认为三种肌钙蛋白在急诊胸痛患者风险分层和安全离院方面效果相同。
- 作者认为达到100%敏感性的理论截断值可能有助于急诊安全离院低危未分化胸痛患者。
适用人群与场景
- 急诊就诊的胸痛患者,入院时接受hsTnT、hsTnI和cTnI检测。
诊断标准与关键阈值
- 改良HEART评分用于将患者分为低危组和非低危组。
- hsTnT截断值3.9ng/L、hsTnI截断值0.9ng/L、cTnI截断值0.0ng/L时,改良HEART评分对30天MACE敏感性达100%。
研究设计与关键结果
- 单中心前瞻性队列研究,纳入急诊胸痛患者,入院时单次采血检测hsTnT、hsTnI和cTnI,按改良HEART评分分为低危和非低危组,主要终点为30天MACE。
- 三种检测方法对应的改良HEART评分对30天MACE的敏感性为84.9-87.0%,NPV为95.6-96.0%(95%CI),AUC为0.70-0.71,特异性为53.7-56.7%(95%CI)。
- 使用hsTnT 3.9ng/L、hsTnI 0.9ng/L或cTnI 0.0ng/L单次采血截断值时,改良HEART评分对30天MACE的敏感性达100%。
证据类型、等级与局限
- 证据类型:单中心前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,使用hsTnT、hsTnI或cTnI的改良HEART评分在急诊胸痛患者风险分层和安全离院方面效果相同。
- 作者认为,达到100%敏感性的理论截断值可能有助于急诊安全离院低危未分化胸痛患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: This study compared the performance of a single blood draw of high-sensitivity troponin T (hsTnT), high-sensitivity troponin I (hsTnI) and conventional troponin I (cTnI) within a modified HEART score for predicting 30-day MACE at Emergency Department (ED) presentation, and established local reference norms for all three assays by determining the cut-off point which yielded the highest sensitivity and negative predictive value for acute myocardial infarction and 30-day MACE.
METHODS: This single-center prospective cohort study recruited chest pain patients at the ED, whose hsTnT, hsTnI and cTnI were taken on admission. Subjects were classified into low and non-low risk group according to their modified HEART score, with MACE as the primary endpoint. Receiver-operating characteristic (ROC) curves were generated, area under the curves (AUCs) were calculated; the performance characteristics were determined.
RESULTS: The performance of modified HEART scores was comparable among the three assays for 30-day MACE (84.9-87.0% sensitivity, 95.6-96.0% NPV, 95%CI) and none of these had very high AUC and specificity (AUC 0.70-0.71, 53.7-56.7% specificity, 95% CI). The modified HEART score using a single blood draw of either hsTnT (3.9ng/L), hsTnI (0.9ng/L) or cTnI (0.0ng/L) at presentation yielded a sensitivity of 100% for 30-day MACE.
CONCLUSION: The modified HEART score using a single blood draw of either hsTnT, hsTnI or cTnI was equally effective in risk-stratifying chest pain patients for safe discharge. The theoretical cut-off points yielding 100% sensitivity are potentially useful (when achieved) for safely discharging low risk patients with undifferentiated chest pain in the ED.
参考来源
- Tan JWC, Tan HJG, Sahlen AO, et al. Performance of cardiac troponins within the HEART score in predicting major adverse cardiac events at the emergency department. Am J Emerg Med. 2019. PMID: 31493982. doi:10.1016/j.ajem.2019.158420
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。